Pharmaceutical Fraud

Pharmaceutical companies have been engaged in fraudulent practices ranging from marketing their drugs for purposes beyond those approved by the FDA to selling drugs which they knew were dangerous to human health as well as paying doctors kickbacks to market their drugs. Settlements and jury verdicts have been quite large in this arena and whistleblowers have recovered millions of dollars in bounty payments for reporting the fraud. In one recent case, Pfizer agreed to pay over $2.3 Billion to the government for its fraudulent marketing of drugs to doctors and the public. Recently, Astra Zeneca agreed to pay $520 million to settle inquiries over its marketing of the antipsychotic drug Seoquel and Eli Lilly last year paid upwards of $1.4 billion to settle an antipsychotic marketing issue.